FDA Approved: FERRIC CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Ferric Citrate from Mylan Pharmaceuticals, approving a supplemental NDA for the product (NDA205874).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Drugs mentioned

• Ferric citrate (ferric citrate)

Snippet

SUPPL AP for FERRIC CITRATE (FERRIC CITRATE)